The Association Between Rheumatic Disease Therapies and Cardiovascular Outcomes in People with HIV—A Retrospective Cohort Study
Titanji B, Nagatomi S, Gallini J, Cui X, Hanberg J, Hsieh E, Marconi V. The Association Between Rheumatic Disease Therapies and Cardiovascular Outcomes in People with HIV—A Retrospective Cohort Study. Journal Of Clinical Medicine 2024, 13: 6209. PMID: 39458159, PMCID: PMC11508247, DOI: 10.3390/jcm13206209.Peer-Reviewed Original ResearchRisk of CVD eventsElectronic health recordsCardiovascular disease eventsCVD eventsRetrospective cohort studyCardiovascular diseaseCohort studyIncidence of CVD eventsIncreased risk of CVD eventsRheumatic diseasesCardiovascular disease outcomesCardiovascular disease riskRisk of cardiovascular diseaseHealth recordsAssociated with increased CVD eventsGeneral populationPrimary outcomeDisease therapyAtlanta VAMCIncreased riskHIV infectionExacerbated inflammationCardiovascular outcomesPatient populationHIVCOVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration
Soyer E, McGinnis K, Justice A, Hsieh E, Rodriguez-Barradas M, Williams E, Park L. COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration. AIDS And Behavior 2024, 28: 3605-3614. PMID: 39046612, DOI: 10.1007/s10461-024-04449-1.Peer-Reviewed Original ResearchHIV statusSubstance use disordersBreakthrough infectionRisk of breakthroughAssociated with increased riskCOVID-19 breakthrough infectionsSARS-CoV-2Association of substance useSARS-CoV-2 infectionHIV treatment adherenceCD4 countHIV progressionSubstance useUnited States Veterans Health AdministrationHazard ratioIncreased riskPWHCD4PWoHHIVUse disorderVaccinated personsCohort of peopleTreatment adherenceLongitudinal cohort